Supplementary Tables: The frequency of major ABCG2, SLCO1B1 and CYP2C9 variants in Asian, Native Hawaiian and Pacific Islander women subgroups: implications for personalized statins dosing

This project was partly supported by the National Institute on Minority Health and Health Disparities 54MD007584, G12MD007601 and the National Institute General Medical Sciences P20GM103466, from the NIH. Y Roman is an employee ofthe US FDA. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. No writing assistance was utilized in the production of this manuscript.